Global Autologous CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 77

Published Date: 06 Sep 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

According to our (Global Info Research) latest study, the global Autologous CAR-T Cell Therapy market size was valued at US$ 3586 million in 2023 and is forecast to a readjusted size of USD 14750 million by 2030 with a CAGR of 21.6% during review period.

Cell immunotherapy techniques, represented by chimeric antigen receptor T-cell immunotherapy (CAR-T therapy), express CAR fusion proteins on the surface of T cells through genetic engineering technology. The CAR extracellular antigen recognition region (one of the components of CAR cells, responsible for recognizing tumor cell surface antigens) can specifically recognize tumor antigens and transmit signals into cells to activate T cells, achieving proliferation and targeted killing of tumor cells. CAR-T therapy has shown breakthrough efficacy and enormous potential for development and market prospects for cancer patients who are unable to cope with traditional treatments. CAR-T cells are divided into autologous and allogeneic CAR-T cells. At present, CAR-T therapy mainly uses autologous CAR-T cells.

In recent years, the progress of autologous CAR-T cell therapy in hematological tumors has inspired scientists to extend this technology to the treatment of solid tumors. However, the current progress in the treatment of solid tumors is relatively slow. But in the future, with the discovery of more targets and the development of clinical trials, solid tumors are expected to become the main treatment area for CAR-T. At present, JW (Cayman) Therapeutics is laying out more innovative products to officially enter the field of cell therapy for solid tumors.

This report is a detailed and comprehensive analysis for global Autologous CAR-T Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Autologous CAR-T Cell Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global Autologous CAR-T Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Autologous CAR-T Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Autologous CAR-T Cell Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Autologous CAR-T Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Autologous CAR-T Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JW (Cayman) Therapeutics, Gilead (Kite Pharma), Bristol Myers Squibb, Novartis, Legend Biotech Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Autologous CAR-T Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Autologous CAR-T Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Target: CD19
    Target: BCMA
    Other

Market segment by Application
    Hematological Tumors
    Solid Tumor

Market segment by players, this report covers
    JW (Cayman) Therapeutics
    Gilead (Kite Pharma)
    Bristol Myers Squibb
    Novartis
    Legend Biotech Corporation

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Autologous CAR-T Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Autologous CAR-T Cell Therapy, with revenue, gross margin, and global market share of Autologous CAR-T Cell Therapy from 2019 to 2024.
Chapter 3, the Autologous CAR-T Cell Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Autologous CAR-T Cell Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Autologous CAR-T Cell Therapy.
Chapter 13, to describe Autologous CAR-T Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Autologous CAR-T Cell Therapy by Type
        1.3.1 Overview: Global Autologous CAR-T Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Autologous CAR-T Cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Target: CD19
        1.3.4 Target: BCMA
        1.3.5 Other
    1.4 Global Autologous CAR-T Cell Therapy Market by Application
        1.4.1 Overview: Global Autologous CAR-T Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hematological Tumors
        1.4.3 Solid Tumor
    1.5 Global Autologous CAR-T Cell Therapy Market Size & Forecast
    1.6 Global Autologous CAR-T Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Autologous CAR-T Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Autologous CAR-T Cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Autologous CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Autologous CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Autologous CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Autologous CAR-T Cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Autologous CAR-T Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 JW (Cayman) Therapeutics
        2.1.1 JW (Cayman) Therapeutics Details
        2.1.2 JW (Cayman) Therapeutics Major Business
        2.1.3 JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Product and Solutions
        2.1.4 JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 JW (Cayman) Therapeutics Recent Developments and Future Plans
    2.2 Gilead (Kite Pharma)
        2.2.1 Gilead (Kite Pharma) Details
        2.2.2 Gilead (Kite Pharma) Major Business
        2.2.3 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product and Solutions
        2.2.4 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Gilead (Kite Pharma) Recent Developments and Future Plans
    2.3 Bristol Myers Squibb
        2.3.1 Bristol Myers Squibb Details
        2.3.2 Bristol Myers Squibb Major Business
        2.3.3 Bristol Myers Squibb Autologous CAR-T Cell Therapy Product and Solutions
        2.3.4 Bristol Myers Squibb Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bristol Myers Squibb Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Autologous CAR-T Cell Therapy Product and Solutions
        2.4.4 Novartis Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 Legend Biotech Corporation
        2.5.1 Legend Biotech Corporation Details
        2.5.2 Legend Biotech Corporation Major Business
        2.5.3 Legend Biotech Corporation Autologous CAR-T Cell Therapy Product and Solutions
        2.5.4 Legend Biotech Corporation Autologous CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Legend Biotech Corporation Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Autologous CAR-T Cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Autologous CAR-T Cell Therapy by Company Revenue
        3.2.2 Top 3 Autologous CAR-T Cell Therapy Players Market Share in 2023
        3.2.3 Top 6 Autologous CAR-T Cell Therapy Players Market Share in 2023
    3.3 Autologous CAR-T Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Autologous CAR-T Cell Therapy Market: Region Footprint
        3.3.2 Autologous CAR-T Cell Therapy Market: Company Product Type Footprint
        3.3.3 Autologous CAR-T Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Autologous CAR-T Cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Autologous CAR-T Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Autologous CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Autologous CAR-T Cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America Autologous CAR-T Cell Therapy Market Size by Application (2019-2030)
    6.3 North America Autologous CAR-T Cell Therapy Market Size by Country
        6.3.1 North America Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Autologous CAR-T Cell Therapy Market Size by Country
        7.3.1 Europe Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America Autologous CAR-T Cell Therapy Market Size by Country
        9.3.1 South America Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Autologous CAR-T Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Autologous CAR-T Cell Therapy Market Drivers
    11.2 Autologous CAR-T Cell Therapy Market Restraints
    11.3 Autologous CAR-T Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Autologous CAR-T Cell Therapy Industry Chain
    12.2 Autologous CAR-T Cell Therapy Upstream Analysis
    12.3 Autologous CAR-T Cell Therapy Midstream Analysis
    12.4 Autologous CAR-T Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Autologous CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Autologous CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Autologous CAR-T Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Autologous CAR-T Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. JW (Cayman) Therapeutics Company Information, Head Office, and Major Competitors
 Table 6. JW (Cayman) Therapeutics Major Business
 Table 7. JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Product and Solutions
 Table 8. JW (Cayman) Therapeutics Autologous CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. JW (Cayman) Therapeutics Recent Developments and Future Plans
 Table 10. Gilead (Kite Pharma) Company Information, Head Office, and Major Competitors
 Table 11. Gilead (Kite Pharma) Major Business
 Table 12. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product and Solutions
 Table 13. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Gilead (Kite Pharma) Recent Developments and Future Plans
 Table 15. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
 Table 16. Bristol Myers Squibb Major Business
 Table 17. Bristol Myers Squibb Autologous CAR-T Cell Therapy Product and Solutions
 Table 18. Bristol Myers Squibb Autologous CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Novartis Company Information, Head Office, and Major Competitors
 Table 20. Novartis Major Business
 Table 21. Novartis Autologous CAR-T Cell Therapy Product and Solutions
 Table 22. Novartis Autologous CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Novartis Recent Developments and Future Plans
 Table 24. Legend Biotech Corporation Company Information, Head Office, and Major Competitors
 Table 25. Legend Biotech Corporation Major Business
 Table 26. Legend Biotech Corporation Autologous CAR-T Cell Therapy Product and Solutions
 Table 27. Legend Biotech Corporation Autologous CAR-T Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Legend Biotech Corporation Recent Developments and Future Plans
 Table 29. Global Autologous CAR-T Cell Therapy Revenue (USD Million) by Players (2019-2024)
 Table 30. Global Autologous CAR-T Cell Therapy Revenue Share by Players (2019-2024)
 Table 31. Breakdown of Autologous CAR-T Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 32. Market Position of Players in Autologous CAR-T Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 33. Head Office of Key Autologous CAR-T Cell Therapy Players
 Table 34. Autologous CAR-T Cell Therapy Market: Company Product Type Footprint
 Table 35. Autologous CAR-T Cell Therapy Market: Company Product Application Footprint
 Table 36. Autologous CAR-T Cell Therapy New Market Entrants and Barriers to Market Entry
 Table 37. Autologous CAR-T Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 38. Global Autologous CAR-T Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
 Table 39. Global Autologous CAR-T Cell Therapy Consumption Value Share by Type (2019-2024)
 Table 40. Global Autologous CAR-T Cell Therapy Consumption Value Forecast by Type (2025-2030)
 Table 41. Global Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2024)
 Table 42. Global Autologous CAR-T Cell Therapy Consumption Value Forecast by Application (2025-2030)
 Table 43. North America Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 44. North America Autologous CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 45. North America Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 46. North America Autologous CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 47. North America Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 48. North America Autologous CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 49. Europe Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 50. Europe Autologous CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 51. Europe Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 52. Europe Autologous CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 53. Europe Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 54. Europe Autologous CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 55. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 56. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 57. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 58. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 59. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 60. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 61. South America Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 62. South America Autologous CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 63. South America Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 64. South America Autologous CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 65. South America Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 66. South America Autologous CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 67. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 68. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 69. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 70. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 71. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 72. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 73. Global Key Players of Autologous CAR-T Cell Therapy Upstream (Raw Materials)
 Table 74. Global Autologous CAR-T Cell Therapy Typical Customers


List of Figures
 Figure 1. Autologous CAR-T Cell Therapy Picture
 Figure 2. Global Autologous CAR-T Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Autologous CAR-T Cell Therapy Consumption Value Market Share by Type in 2023
 Figure 4. Target: CD19
 Figure 5. Target: BCMA
 Figure 6. Other
 Figure 7. Global Autologous CAR-T Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Autologous CAR-T Cell Therapy Consumption Value Market Share by Application in 2023
 Figure 9. Hematological Tumors Picture
 Figure 10. Solid Tumor Picture
 Figure 11. Global Autologous CAR-T Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Autologous CAR-T Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Market Autologous CAR-T Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 14. Global Autologous CAR-T Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 15. Global Autologous CAR-T Cell Therapy Consumption Value Market Share by Region in 2023
 Figure 16. North America Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 17. Europe Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. South America Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. Company Three Recent Developments and Future Plans
 Figure 22. Global Autologous CAR-T Cell Therapy Revenue Share by Players in 2023
 Figure 23. Autologous CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 24. Market Share of Autologous CAR-T Cell Therapy by Player Revenue in 2023
 Figure 25. Top 3 Autologous CAR-T Cell Therapy Players Market Share in 2023
 Figure 26. Top 6 Autologous CAR-T Cell Therapy Players Market Share in 2023
 Figure 27. Global Autologous CAR-T Cell Therapy Consumption Value Share by Type (2019-2024)
 Figure 28. Global Autologous CAR-T Cell Therapy Market Share Forecast by Type (2025-2030)
 Figure 29. Global Autologous CAR-T Cell Therapy Consumption Value Share by Application (2019-2024)
 Figure 30. Global Autologous CAR-T Cell Therapy Market Share Forecast by Application (2025-2030)
 Figure 31. North America Autologous CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 32. North America Autologous CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 33. North America Autologous CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 34. United States Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 35. Canada Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 36. Mexico Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 37. Europe Autologous CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 38. Europe Autologous CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 39. Europe Autologous CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 40. Germany Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 41. France Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 42. United Kingdom Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 43. Russia Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 44. Italy Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 45. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 46. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 47. Asia-Pacific Autologous CAR-T Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 48. China Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 49. Japan Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 50. South Korea Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 51. India Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 52. Southeast Asia Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 53. Australia Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 54. South America Autologous CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 55. South America Autologous CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 56. South America Autologous CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 57. Brazil Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 58. Argentina Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 59. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 60. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 61. Middle East & Africa Autologous CAR-T Cell Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 62. Turkey Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 63. Saudi Arabia Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 64. UAE Autologous CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 65. Autologous CAR-T Cell Therapy Market Drivers
 Figure 66. Autologous CAR-T Cell Therapy Market Restraints
 Figure 67. Autologous CAR-T Cell Therapy Market Trends
 Figure 68. Porters Five Forces Analysis
 Figure 69. Autologous CAR-T Cell Therapy Industrial Chain
 Figure 70. Methodology
 Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

JW (Cayman) Therapeutics
Gilead (Kite Pharma)
Bristol Myers Squibb
Novartis
Legend Biotech Corporation

Related Reports

Global Autologous CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

Global Autologous CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

date 06 Sep 2024

date Medical Care

CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.

Product Tags

Autologous CAR-T Cell Therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>